tiprankstipranks
Trending News
More News >
Cosmo Bio Co., Ltd. (JP:3386)
:3386
Japanese Market

Cosmo Bio Co., Ltd. (3386) Income Statement

Compare
0 Followers

Cosmo Bio Co., Ltd. Income Statement

Last quarter (Q2 2025), Cosmo Bio Co., Ltd.'s total revenue was ¥2.31B, an increase of 5.63% from the same quarter last year. In Q2, Cosmo Bio Co., Ltd.'s net income was ¥37.00M. See Cosmo Bio Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 10.04B¥ 9.34B¥ 9.55B¥ 9.23B¥ 8.09B
Gross Profit
¥ 3.33B¥ 3.25B¥ 3.44B¥ 3.66B¥ 3.15B
Operating Expenses
¥ 3.01B¥ 2.73B¥ 2.62B¥ 2.61B¥ 2.40B
Depreciation and Amortization
¥ 136.00M¥ 148.00M¥ 141.00M¥ 166.00M¥ 175.00M
EBITDA
¥ 455.00M¥ 801.00M¥ 931.00M¥ 1.26B¥ 1.18B
Operating Income
¥ 318.00M¥ 519.00M¥ 816.00M¥ 1.05B¥ 752.00M
Other Income/Expenses
¥ 50.00M¥ 134.00M¥ -26.00M¥ 51.00M¥ 256.00M
Pretax Income
¥ 369.00M¥ 653.00M¥ 790.00M¥ 1.10B¥ 1.01B
Net Income
¥ 262.00M¥ 442.00M¥ 517.00M¥ 737.00M¥ 674.00M
Per Share Metrics
Basic EPS
¥ 45.05¥ 75.83¥ 89.13¥ 126.94¥ 113.70
Diluted EPS
¥ 45.05¥ 75.83¥ 89.13¥ 126.94¥ 113.70
Weighted Average Shares Outstanding
5.82M 5.83M 5.81M 5.81M 5.93M
Weighted Average Shares Outstanding (Diluted)
5.82M 5.83M 5.81M 5.81M 5.93M
Currency in JPY

Cosmo Bio Co., Ltd. Earnings and Revenue History